$9.93
0.080.81%
At close: Aug 11, 5:00 PM EST
$9.93
N/A
After Hours: 7:30 PM EST
Kura Oncology (KURA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.88 | $-0.80 | $-0.58 | $-0.63 |
| Actual | — | $-0.83 | $-0.92 | $-0.85 |
| Surprise | — | -3.75% | -58.6% | -34.9% |
| Revenue | ||||
| Estimate | $19.5M | $23.7M | $33.2M | $62.0M |
| Actual | — | $18.3M | $17.3M | $20.8M |
| Surprise | — | -23.1% | -47.8% | -66.5% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-0.90 | $-0.84 | $-0.61 |
| Revenue | |||
| Consensus | $22.7M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q1 | May 12, 2026 | $-0.83 | $-0.80 | -3.75 % |
| Q4 | Mar 5, 2026 | $-0.92 | $-0.58 | -58.6 % |
| Q3 | Nov 4, 2025 | $-0.85 | $-0.63 | -34.9 % |
| Q2 | Aug 7, 2025 | $-0.75 | $-0.16 | -368.8 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q1 | May 12, 2026 | $18.27M | $23.75M | -23.1 % |
| Q4 | Mar 5, 2026 | $17.34M | $33.20M | -47.8 % |
| Q3 | Nov 4, 2025 | $20.75M | $61.98M | -66.5 % |
| Q2 | Aug 7, 2025 | $15.29M | $95.74M | -84.0 % |